161229-01-2

Usage

Uses

Used in Organic Synthesis:
(S)-1-(3,4-DICHLORO-PHENYL)-3-DIMETHYLAMINO-PROPAN-1-OL is used as a building block for creating diverse chemical compounds due to its unique structure and properties.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (S)-1-(3,4-DICHLORO-PHENYL)-3-DIMETHYLAMINO-PROPAN-1-OL is utilized as a key intermediate in the development of new drugs, leveraging its stereochemistry and functional groups to enhance drug efficacy and selectivity.
Used in Medicinal Product Development:
(S)-1-(3,4-DICHLORO-PHENYL)-3-DIMETHYLAMINO-PROPAN-1-OL is employed as a starting material in the synthesis of medicinal compounds, contributing to the discovery of novel therapeutic agents with improved pharmacological profiles.
Used in Agricultural Product Development:
In agriculture, (S)-1-(3,4-DICHLORO-PHENYL)-3-DIMETHYLAMINO-PROPAN-1-OL is used as a precursor in the synthesis of agrochemicals, such as pesticides and herbicides, to develop more effective and environmentally friendly products.

InChI:InChI=1/C11H15Cl2NO/c1-14(2)6-5-11(15)8-3-4-9(12)10(13)7-8/h3-4,7,11,15H,5-6H2,1-2H3/t11-/m0/s1

Upstream product

• 50516-63-7 1-(3,4-dichlorophenyl)-3-(dimethylamino)-1-propanone 
• 2642-63-9 3',4'-dichloroacetophenone 

Downstream Products

• 1346460-40-9 3-(3,4-dichlorophenyl)-N,N-dimethyl-3-morpholinopropan-1-amine hydrochloride 
• 1346460-43-2 3-(3,4-dichlorophenyl)-N,N-dimethyl-3-(piperidin-1-yl)propan-1-amine hydrochloride 
• 1346460-39-6 3-(3,4-dichlorophenyl)-N,N-dimethyl-3-(piperazin-1-yl)propan-1-amine hydrochloride 
• 1346460-38-5 3-(3,4-dichlorophenyl)-N,N-dimethyl-3-(pyrrolidin-1-yl)propan-1-amine hydrochloride 
• 1198348-58-1 [3-(3,4-dichloro-phenyl)-3-tetrazol-2-yl-propyl]-methyl-amine 
• 1198348-59-2 (S)-[3-(3,4-dichloro-phenyl)-3-tetrazol-2-yl-propyl]-methyl-amine 

Relevant academic research and scientific papers

3-[(BENZO[D][1,3]DIOXOLAN-4-YL)-OXY]-3-ARYLPROPYLAMINE TYPE COMPOUNDS AND APPLICATIONS THEREOF

The present invention relates to 3-[(benzo[d][1,3]dioxolan-4-yl)-oxy]-3-arylpropylamine compounds of formula I or pharmaceutically acceptable salts thereof and use thereof. The compound may be used to prepare an antidepressant agent.

ARALKYL DIAMINE DERIVATIVES AND USES THEREOF AS ANTIDEPRESSANT

Aralkyl diamine derivative of the following formula, pharmaceutically acceptable salts or uses thereof as antidepressants. The derivatives have triplex inhibiting activities of the reuptake of 5-HT, dopamine and noradrenalin, which can be administered to the patients in need of such treatment in the form of compositions orally or injectedly et al.

Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors

A series of 3-aryl-3-azolylpropan-1-amines was prepared and screened for its capability of inhibiting monoamine reuptake. Analogs with nanomolar potency, good human in vitro microsomal stability, and low drug-drug interaction potential were described. In

3-Substituted Propanamine Compounds

Racemic or enantiomerically enriched 3-substituted propanamine compounds represented by the following structural formula (I): or a pharmaceutically acceptable salt thereof are disclosed. Pharmaceutical compositions containing the subject compounds are als

3-SUBSTITUTED PROPANAMINE COMPOUNDS

Racemic or enantiomerically enriched 3-substituted propanamine compounds represented by the following structural formula (I) or a pharmaceutically acceptable salt thereof are disclosed. Pharmaceutical compositions containing the subject compounds are also

Enantioselective Oxazaborolidine Reduction of Ketones Containing Heteroatoms

Ketones which contain heteroatoms, particularly nitrogen, can be enantioselectively and catalytically reduced with chiral oxazaborolidines in the presence of excess borane. Key Words: Enantioselective reduction; Oxazaborolidine; Chiral alcohol; Catalytic reduction; Amine-borane

Diphenyloxazaborolidine a new catalyst for enantioselective reduction of ketones

A variety of ketones can be reduced in high enantioselectivity with the oxazaborolidines derived from commercially available erythro aminodiphenylethanol.